Hypogammaglobulinemia in rheumatoid arthritis patients on rituximab: prevalence and risk factors

Journal Article Corrected proof Hypogammaglobulinemia in rheumatoid arthritis patients on rituximab: prevalence and risk factors Get access Merel A A Opdam, Merel A A Opdam Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The NetherlandsRadboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands Correspondence to: Merel A. A. Opdam, Department of Rheumatology, Sint Maartenskliniek, Antwoordnummer 2237, 6500 WC Nijmegen, The Netherlands. E-mail: M.Opdam@maartenskliniek.nl https://orcid.org/0000-0003-3385-8807 Search for other works by this author on: Oxford Academic PubMed Google Scholar Laura M Campisi, Laura M Campisi Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands Search for other works by this author on: Oxford Academic PubMed Google Scholar J H de Leijer, J H de Leijer Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands Search for other works by this author on: Oxford Academic PubMed Google Scholar David ten Cate, David ten Cate Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands Search for other works by this author on: Oxford Academic PubMed Google Scholar Alfons A den Broeder Alfons A den Broeder Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The NetherlandsDepartment of Rheumatology, Radboudumc, Nijmegen, The Netherlands Search for other works by this author on: Oxford Academic PubMed Google Scholar Rheumatology, kead326, https://doi.org/10.1093/rheumatology/kead326 Published: 06 July 2023 Article history Accepted: 17 June 2023 Published: 06 July 2023 Corrected and typeset: 19 July 2023